Navigation Links
Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast

PLEASANTON, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fiscal 2008 year on Thursday, February 5.

The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Standard Time (4:30 p.m., Eastern Standard Time), Thursday, February 5, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief financial officer.

    The teleconference can be accessed by calling (719) 325-2390, passcode
7541788. Please dial in 10-15 minutes prior to the beginning of the call.
The webcast will be available on the Internet at
eventDetails&c=95989&eventID=2073636 or at

A replay of the conference call will be available through Thursday, February 12, via or by telephone at (719) 457-0820, passcode 7541788.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at or

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thoratec Presentation at Piper Jaffary Conference to be Webcast
2. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
3. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
4. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
5. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
6. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
7. Thoratecs ITC Division Receives FDA Warning Letter
8. Thoratec Schedules Third Quarter Conference Call, Webcast
9. Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009
10. Triple-S Management Corporation Schedules Fourth-Quarter and Year-End Earnings Release and Webcast
11. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 9, 2009
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog ... effect tool designed specially for Final Cut Pro X. FCPX users ... the easy-to-use modification controls. Destoying and creating chaotic distortion is now quick and ...
(Date:11/28/2015)... ... ... Trying to relax on a couch can actually be uncomfortable, so an ... due to personal experience with a bad back," he said. , This easy-to-use, versatile ... as increases support. It also makes it easier to eat, do other activities and ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the toilets were," said an inventor from Hillside, N.J. "Many people catch diseases ... cover so that individuals will always be protected from germs." , He developed ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the ... 2016 Building Better Radiology Marketing Programs meeting will showcase some of the ... 2016, at Caesars Palace in Las Vegas with a pre-conference session on a ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... Une nouvelle approche consistant à combiner l,immunothérapie au ...    Clinical Cancer Research . ...
(Date:11/27/2015)... DUBLIN , Nov. 26, 2015 /PRNewswire/ ... announced the addition of the "2016 ... by Test, Country Volume and Sales Segment ... Emerging Opportunities" report to their offering. ... the addition of the "2016 Global ...
(Date:11/26/2015)... , Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met ... kanker. ) ...      (Photo: ) ... Leids Universitair Medisch Centrum (LUMC) ...
Breaking Medicine Technology: